Antibodies Contract Manufacturing Market Size, Share & Trends Report

Antibodies Contract Manufacturing Market Size, Share & Trends Analysis Report, By Product (Monoclonal Antibodies, Polyclonal Antibodies, Others), By Source, By End Use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-920-3
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. Source
                       1.1.3. End User
                       1.1.4. Regional scope
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1:
                       1.9.2. Objective 2:
                       1.9.3. Objective 3:
                       1.9.4. Objective 4:
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. Antibody Contract Manufacturing Market Variables, Trends & Scope
                   3.1. Penetration & Growth Prospect Mapping
                   3.2. Industry Value Chain Analysis
                       3.2.1. Reimbursement framework
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                       3.3.3. Industry challenges
                   3.4. Antibody Contract Manufacturing Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s Five Forces
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
                       3.4.3. Major Deals & Strategic Alliances Analysis
                       3.4.4. Market Entry Strategies
                       3.4.5. COVID-19 Analysis
Chapter 4. Antibody Contract Manufacturing Market: Product Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. Definitions and Scope
                   4.3. Antibody Contract Manufacturing Market Share, 2021 & 2030
                   4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
                       4.4.1. Monoclonal Antibodies
                       4.4.2. Polyclonal Antibodies
                       4.4.3. Others
Chapter 5. Antibody Contract Manufacturing Market: Source Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. Definitions and Scope
                   5.3. Antibody Contract Manufacturing Market Share, 2021 & 2030
                   5.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
                       5.4.1. Mammalian
                       5.4.2. Microbial
Chapter 6. Antibody Contract Manufacturing Market: End User Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. Definitions and Scope
                   6.3. Antibody Contract Manufacturing Market Share, 2021 & 2030
                   6.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
                       6.4.1. Biopharmaceutical Companies
                       6.4.2. Research Laboratories
                       6.4.3. Others
Chapter 7. Antibody Contract Manufacturing Market: Regional Estimates & Trend Analysis
                   7.1. Regional Market Dashboard
                   7.2. Regional Market Share Analysis, 2021 & 2030
                   7.3. Regional Market Share, 2020
                   7.4. North America
                       7.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.4.2. U.S.
                           7.4.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.4.3. Canada
                           7.4.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                   7.5. Europe
                       7.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.5.2. U.K.
                           7.5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.5.3. Germany
                           7.5.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.5.4. France
                           7.5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.5.5. Spain
                           7.5.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.5.6. Italy
                           7.5.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                   7.6. Asia Pacific
                       7.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.6.2. Japan
                           7.6.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.6.3. China
                           7.6.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.6.4. India
                           7.6.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.6.5. Australia
                           7.6.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.6.6. South Korea
                           7.6.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                   7.7. Latin America
                       7.7.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.7.2. Brazil
                           7.7.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.7.3. Argentina
                           7.7.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.7.4. Mexico
                           7.7.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.7.5. Colombia
                           7.7.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.7.6. Chile
                           7.7.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                   7.8. MEA
                       7.8.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.8.2. South Africa
                           7.8.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.8.3. UAE
                           7.8.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
                       7.8.4. Egypt
                           7.8.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                       8.1.1. Lonza
                           8.1.1.1. Company overview
                           8.1.1.2. Financial performance
                           8.1.1.3. Product benchmarking
                           8.1.1.4. Strategic initiatives
                       8.1.2. Samsung Biologics
                           8.1.2.1. Company overview
                           8.1.2.2. Financial performance
                           8.1.2.3. Product benchmarking
                           8.1.2.4. Strategic initiatives
                       8.1.3. WuXi Biologics.
                           8.1.3.1. Company overview
                           8.1.3.2. Financial performance
                           8.1.3.3. Product benchmarking
                           8.1.3.4. Strategic initiatives
                       8.1.4. Charles River Laboratories
                           8.1.4.1. Company overview
                           8.1.4.2. Financial performance
                           8.1.4.3. Product benchmarking
                           8.1.4.4. Strategic initiatives
                       8.1.5. FUJIFILM Holdings Corporation
                           8.1.5.1. Company overview
                           8.1.5.2. Financial performance
                           8.1.5.3. Product benchmarking
                           8.1.5.4. Strategic initiatives
                       8.1.6. Boehringer Ingelheim Biopharmaceuticals GmbH.
                           8.1.6.1. Company overview
                           8.1.6.2. Financial performance
                           8.1.6.3. Product benchmarking
                           8.1.6.4. Strategic initiatives
                       8.1.7. AGC Biologics
                           8.1.7.1. Company overview
                           8.1.7.2. Financial performance
                           8.1.7.3. Product benchmarking
                           8.1.7.4. Strategic initiatives
                       8.1.8. Cytovance Biologics, Inc.
                           8.1.8.1. Company overview
                           8.1.8.2. Financial performance
                           8.1.8.3. Product benchmarking
                           8.1.8.4. Strategic initiatives
                       8.1.9. EMERGENT
                           8.1.9.1. Company overview
                           8.1.9.2. Financial performance
                           8.1.9.3. Product benchmarking
                           8.1.9.4. Strategic initiatives
                       8.1.10. Thermo Fisher Scientific
                           8.1.10.1. Company overview
                           8.1.10.2. Financial performance
                           8.1.10.3. Product benchmarking
                           8.1.10.4. Strategic initiatives
                       8.1.11. Laboratory Corporation of America Holdings
                           8.1.11.1. Company overview
                           8.1.11.2. Financial performance
                           8.1.11.3. Product benchmarking
                           8.1.11.4. Strategic initiatives
                       8.1.12. Catalent, Inc
                           8.1.12.1. Company overview
                           8.1.12.2. Financial performance
                           8.1.12.3. Product benchmarking
                           8.1.12.4. Strategic initiatives


List of Tables

Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global Antibody Contract Manufacturing Market, by Region 2017 - 2030 (USD Million)
Table 4 Global Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 5 Global Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 6 Global Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 7 North America Antibody Contract Manufacturing Market, by Country, 2017 - 2030 (USD Million)
Table 8 North America Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 9 North America Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 10 North America Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 11 U.S. Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 12 U.S. Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 13 U.S. Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 14 Canada Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 15 Canada Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 16 Canada Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 17 Europe Antibody Contract Manufacturing Market, by Country, 2017 - 2030 (USD Million)
Table 18 Europe Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 19 Europe Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 20 Europe Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 21 U.K. Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 22 U.K. Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 23 U.K. Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 24 Germany Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 25 Germany Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 26 Germany Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 27 France Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 28 France Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 29 France Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 30 Italy Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 31 Italy Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 32 Italy Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 33 Spain Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 34 Spain Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 35 Spain Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 36 Asia Pacific Antibody Contract Manufacturing Market, by Country, 2017 - 2030 (USD Million)
Table 37 Asia Pacific Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 38 Asia Pacific Discovery Outsourcing Market, by Source, 2017 - 2030 (USD Million)
Table 39 Asia Pacific Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 40 Japan Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 41 Japan Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 42 Japan Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 43 China Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 44 China Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 45 China Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 46 India Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 47 India Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 48 India Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 49 Australia Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 50 Australia Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 51 Australia Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 52 South Korea Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 53 South Korea Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 54 South Korea Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 55 Latin America Antibody Contract Manufacturing Market, by Country, 2017 - 2030 (USD Million)
Table 56 Latin America Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 57 Latin America Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 58 Latin America Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 59 Brazil Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 60 Brazil Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 61 Brazil Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 62 Mexico Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 63 Mexico Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 64 Mexico Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 65 Argentina Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 66 Argentina Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 67 Argentina Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 68 Colombia Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 69 Colombia Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 70 Colombia Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 71 Chile Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 72 Chile Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 73 Chile Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 74 MEA Antibody Contract Manufacturing Market, by Country, 2017 - 2030 (USD Million)
Table 75 MEA Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 76 MEA Antibody Contract Manufacturing Market, by Source, 2017 - 2030 (USD Million)
Table 77 MEA Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 78 South Africa Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 79 South Africa Discovery Outsourcing Market, by Source, 2017 - 2030 (USD Million)
Table 80 South Africa Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 81 UAE Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 82 UAE Discovery Outsourcing Market, by Source, 2017 - 2030 (USD Million)
Table 83 UAE Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)
Table 84 Egypt Antibody Contract Manufacturing Market, by Product, 2017 - 2030 (USD Million)
Table 85 Egypt Discovery Outsourcing Market, by Source, 2017 - 2030 (USD Million)
Table 86 Egypt Antibody Contract Manufacturing Market, by End User, 2017 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Antibody Contract Manufacturing market: Market snapshot
Fig. 9 Antibody Contract Manufacturing market: Market segmentation
Fig. 10 Antibody Contract Manufacturing market: Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Antibody Contract Manufacturing market driver impact
Fig. 14 Antibody Contract Manufacturing market restraint impact
Fig. 15 Antibody Contract Manufacturing market porter’s five forces analysis
Fig. 16 Antibody Contract Manufacturing market PESTEL analysis
Fig. 17 Antibody Contract Manufacturing market segment dashboard
Fig. 18 Antibody Contract Manufacturing market: Product movement Analysis
Fig. 19 Monoclonal Antibodies Antibody Contract Manufacturing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 20 Polyclonal Antibodies Antibody Contract Manufacturing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 21 Others Antibody Contract Manufacturing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 22 Antibody Contract Manufacturing market segment dashboard
Fig. 23 Mammalian Antibody Contract Manufacturing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 24 Microbial Antibody Contract Manufacturing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 25 Global Antibody Contract Manufacturing market: Regional movement analysis
Fig. 26 Global market share, by region
Fig. 27 North America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 28 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 29 Canada market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 30 Europe market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 31 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 32 Germany market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 33 France market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 34 Italy market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 35 Spain market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 36 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 37 Japan market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 38 China market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 39 India market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 40 Australia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 41 South Korea market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 42 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 43 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 44 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 45 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 46 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 47 Chile market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 48 Middle East and Africa market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 49 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 50 UAE market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 51 Egypt market estimates and forecast, 2017 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon